Your browser doesn't support javascript.
loading
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III, Randomized, Double-Blind, Comparative Trial.
Xu, Jie; Wang, Anxin; Meng, Xia; Yalkun, Gulbahram; Xu, Anding; Gao, Zhiqiang; Chen, Huisheng; Ji, Yong; Xu, Jun; Geng, Deqin; Zhu, Runxiu; Liu, Bo; Dong, Aiqin; Mu, Hua; Lu, Zhihong; Li, Shuya; Zheng, Huaguang; Chen, Xia; Wang, Yilong; Zhao, Xingquan; Wang, Yongjun.
Affiliation
  • Xu J; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China (Jie Xu, A.W., X.M., G.Y., S.L., H.Z., X.C., Yilong Wang, X.Z., Yongjun Wang).
  • Wang A; China National Clinical Research Center for Neurological Diseases, Beijing (Jie Xu, A.W., X.M., G.Y., S.L., H.Z., X.C., Yilong Wang, X.Z., Yongjun Wang).
  • Meng X; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China (Jie Xu, A.W., X.M., G.Y., S.L., H.Z., X.C., Yilong Wang, X.Z., Yongjun Wang).
  • Yalkun G; China National Clinical Research Center for Neurological Diseases, Beijing (Jie Xu, A.W., X.M., G.Y., S.L., H.Z., X.C., Yilong Wang, X.Z., Yongjun Wang).
  • Xu A; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China (Jie Xu, A.W., X.M., G.Y., S.L., H.Z., X.C., Yilong Wang, X.Z., Yongjun Wang).
  • Gao Z; China National Clinical Research Center for Neurological Diseases, Beijing (Jie Xu, A.W., X.M., G.Y., S.L., H.Z., X.C., Yilong Wang, X.Z., Yongjun Wang).
  • Chen H; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China (Jie Xu, A.W., X.M., G.Y., S.L., H.Z., X.C., Yilong Wang, X.Z., Yongjun Wang).
  • Ji Y; China National Clinical Research Center for Neurological Diseases, Beijing (Jie Xu, A.W., X.M., G.Y., S.L., H.Z., X.C., Yilong Wang, X.Z., Yongjun Wang).
  • Xu J; Department of Neurology and Stroke Center, The First Affiliated Hospital of Jinan University, Guangzhou, China (A.X.).
  • Geng D; Department of Neurology, The Second Affiliated Hospital of Nanjing Medical University, China (Z.G.).
  • Zhu R; Department of Neurology, The General Hospital of Shenyang Military, China (H.C.).
  • Liu B; Department of Neurology, Tianjin Huanhu Hospital, China (Y.J.).
  • Dong A; Department of Neurology, Subei People's Hospital of Jiangsu Province, Yangzhou, China (Jun Xu).
  • Mu H; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, China (D.G.).
  • Lu Z; Department of Neurology, Inner Mongolia Autonomous Region People's Hospital, Hohhot, China (R.Z.).
  • Li S; Department of Neurology, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, China (B.L.).
  • Zheng H; Department of Neurology, Cangzhou Central Hospital, China (A.D.).
  • Chen X; State Key Laboratory of Translational Medicine and Innovative Drug Development, Nanjing, China (H.M., Z.L.).
  • Wang Y; State Key Laboratory of Translational Medicine and Innovative Drug Development, Nanjing, China (H.M., Z.L.).
  • Zhao X; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China (Jie Xu, A.W., X.M., G.Y., S.L., H.Z., X.C., Yilong Wang, X.Z., Yongjun Wang).
  • Wang Y; China National Clinical Research Center for Neurological Diseases, Beijing (Jie Xu, A.W., X.M., G.Y., S.L., H.Z., X.C., Yilong Wang, X.Z., Yongjun Wang).
Stroke ; 52(3): 772-780, 2021 03.
Article in En | MEDLINE | ID: mdl-33588596
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Camphanes / Neuroprotective Agents / Edaravone / Ischemic Stroke / Anti-Inflammatory Agents / Antioxidants Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Language: En Journal: Stroke Year: 2021 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Camphanes / Neuroprotective Agents / Edaravone / Ischemic Stroke / Anti-Inflammatory Agents / Antioxidants Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Language: En Journal: Stroke Year: 2021 Type: Article